2011 Highlights

participants from all sectors of the medical research enterprise, across therapeutic areas, and across geographic boundaries


speakers who have shaped markets engaged in dynamic, candid discussions on issues that matter (75% of speakers are new to this meeting)

plenary and breakout panel discussions that focused on transformative ideas, best practices, and lessons learned

collaborative programs presented their novel approaches to commercialization, academic translational efforts, data sharing initiatives, drug repurposing programs, clinical trials innovations, and intellectual property management

experts on-site provided one-on-one pro-bono consultations with the goal of paying it forward and accelerating the process by making their expertise accessible

individual one-on-one pre-scheduled meetings that connected leaders from across sectors, disciplines, and areas of expertise

Numerous possibilities for productive collisions and results-oriented networking
Priming The Pump: Filling the Therapeutic Pipeline
Intersection of Human, Social, and Financial Capital
B2B hp
Back to Basics: Patient Activism Thirty Years After HIV/AIDS

tue plen1 HPWho Will Pay for Tomorrow's Medical Breakthroughs?

Partnering For Cures Outcomes

In its 3rd year, Partnering for Cures has led to a number of tangible successes: